3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
15
Stomach Neoplasms
8
Carcinoma, Hepatocellular
8
Rectal Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Neoplasms
6
Neoplasm Metastasis
6
Ovarian Neoplasms
5
Brain Neoplasms
5
Thyroid Neoplasms
4
Sarcoma
4
Recurrence
4
Urinary Bladder Neoplasms
3
Pilonidal Sinus
3
Pancreatic Neoplasms
3
Neoplastic Cells, Circulating
3
Melanoma
3
Lung Neoplasms
3
Kidney Neoplasms
3
Glioblastoma
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Peritoneal Neoplasms
2
Pain, Postoperative
2
Pain
2
Oropharyngeal Neoplasms
2
Oligodendroglioma
2
Liver Neoplasms
2
Gastrointestinal Stromal Tumors
2
Interventions
regorafenib
1
X-Rays
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Radiotherapy
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Fluorouracil
1
Exercise
1
Endoscopy
1
Chemoradiotherapy
1
Cell-Free Nucleic Acids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Pathologic Complete Response
×
Surgical Procedures, Operative
×
Clear all
NCT03125343
2023-11-07
WoW
Sahlgrenska University Hospital
Phase NA
Recruiting
400 enrolled